Amyris Biotechnologies, Inc., an Emeryville, CA-based company that produces and supplies renewable chemicals and transportation fuels, has received a $47.8m investment from Temasek Holdings.
The company will use the funds to support commercial plant design and construction activities as well as ongoing operations in the U.S. and Brazil.
Since inception in 2003, Amyris has secured $244m in private funding.
This sum includes funding directly into Amyris Biotechnologies and into its subsidiary, Amyris Brasil S.A.
Investors in the company include Kleiner Perkins Caufield & Byers, Khosla Ventures, TPG Biotechnology, Votorantim Novos Negocios, Advanced Equities Inc., DAG Ventures, Grupo Cornélio Brennand, Naxos U.K., The Westly Group, and Stratus Group.